American Association for the Advancement of Science, Science Translational Medicine, 446(10), 2018
DOI: 10.1126/scitranslmed.aao2565
Elsevier, European Journal of Cancer, (61), p. S96
DOI: 10.1016/s0959-8049(16)61337-0
Full text: Unavailable
G12 mutant KRAS requires tonic ERBB network activity for initiation and maintenance of lung cancer.